Key facts
- This page summarizes Powl Brian T.'s Form 4 filing for Kura Oncology, Inc. (KURA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jan 2026, 16:30.
Powl Brian T. - 02 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- KURA
- Reported as of
- 02 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jan 2026, 16:30:07 UTC
- Prior SEC filing
- 14 Nov 2025
- Next SEC filing
- 27 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- Teresa Bair, Attorney-in-fact for Brian Powl
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Powl Brian T. filed Form 4 for Kura Oncology, Inc. (KURA) on 06 Jan 2026.
Change
- Previous filing in this sequence was filed on 14 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001934232
Primary reporting owner
Powl Brian T.
- Relationship
- Chief Commercial Officer
- Address
- C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO
- Signature
- Teresa Bair, Attorney-in-fact for Brian Powl
- Signature date
- 06 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KURA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- +36%
- Price
- $0.000000
- Shares after
- 189,689
- Date
- 02 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KURA
transaction
Derivative
Option to purchase common stock
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- Price
- $0.000000
- Shares after
- 100,000
- Date
- 02 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $10.34
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30.
Footnote F2
This option vests in 48 equal monthly installments commencing on the grant date.